Literature DB >> 20688274

Clinical implementation of the intrinsic subtypes of breast cancer.

Charles M Perou, Joel S Parker, Aleix Prat, Matthew J Ellis, Philip S Bernard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20688274     DOI： 10.1016/S1470-2045(10)70176-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  43 in total

Review 1.  Practical implications of gene-expression-based assays for breast oncologists.

Authors:  Aleix Prat; Matthew J Ellis; Charles M Perou
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

2.  A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer.

Authors:  Benjamin T Spike; Dannielle D Engle; Jennifer C Lin; Samantha K Cheung; Justin La; Geoffrey M Wahl
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

3.  Cancer progression modeling using static sample data.

Authors:  Yijun Sun; Jin Yao; Norma J Nowak; Steve Goodison
Journal:  Genome Biol       Date:  2014-08-26       Impact factor: 13.583

4.  Standardized versus research-based PAM50 intrinsic subtyping of breast cancer.

Authors:  A Prat; J S Parker
Journal:  Clin Transl Oncol       Date:  2019-08-21       Impact factor: 3.405

5.  A three-gene model to robustly identify breast cancer molecular subtypes.

Authors:  Benjamin Haibe-Kains; Christine Desmedt; Sherene Loi; Aedin C Culhane; Gianluca Bontempi; John Quackenbush; Christos Sotiriou
Journal:  J Natl Cancer Inst       Date:  2012-01-18       Impact factor: 13.506

6.  Age-specific changes in intrinsic breast cancer subtypes: a focus on older women.

Authors:  Emily O Jenkins; Allison M Deal; Carey K Anders; Aleix Prat; Charles M Perou; Lisa A Carey; Hyman B Muss
Journal:  Oncologist       Date:  2014-08-20

7.  Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breaty st Tumors from the NCCTG (Alliance) N9831 Trial.

Authors:  Edith A Perez; Karla V Ballman; Afshin Mashadi-Hossein; Kathleen S Tenner; Jennifer M Kachergus; Nadine Norton; Brian M Necela; Jennifer M Carr; Sean Ferree; Charles M Perou; Frederick Baehner; Maggie Chon U Cheang; E Aubrey Thompson
Journal:  J Natl Cancer Inst       Date:  2016-10-28       Impact factor: 13.506

Review 8.  How many etiological subtypes of breast cancer: two, three, four, or more?

Authors:  William F Anderson; Philip S Rosenberg; Aleix Prat; Charles M Perou; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2014-08-12       Impact factor: 13.506

Review 9.  Insight into the heterogeneity of breast cancer through next-generation sequencing.

Authors:  Hege G Russnes; Nicholas Navin; James Hicks; Anne-Lise Borresen-Dale
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

10.  Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility.

Authors:  P Sinn; S Aulmann; R Wirtz; S Schott; F Marmé; Z Varga; A Lebeau; H Kreipe; A Schneeweiss
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.